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A B S T R A C T
Buruli ulcer (BU) is a necrotizing infection of the skin and subcutaneous tissue caused byMycobacterium ulcerans.
BU wounds may also be colonized with other microorganisms including Staphylococcus aureus. This study aimed
to characterize the virulence factors of S. aureus isolated from BU patients. Previously sequenced genomes of 21
S. aureus isolates from BU patients were screened for the presence of virulence genes. The results show that all S.
aureus isolates harbored on their core genomes genes for known virulence factors like α-hemolysin, and the α-
and β-phenol soluble modulins. Besides the core genome virulence genes, mobile genetic elements (MGEs), i.e.
prophages, genomic islands, pathogenicity islands and a Staphylococcal cassette chromosome (SCC) were found
to carry diﬀerent combinations of virulence factors, among them genes that are known to encode factors that
promote immune evasion, superantigens and Panton-Valentine Leucocidin. The present observations imply that
the S. aureus isolates from BU patients harbor a diverse repertoire of virulence genes that may enhance bacterial
survival and persistence in the wound environment and potentially contribute to delayed wound healing.
1. Introduction
Staphylococcus aureus is one of the most common bacteria residing in
chronic wounds, including the Buruli ulcers (BU) caused by
Mycobacterium ulcerans (Amissah et al., 2015b; Barogui et al., 2013).
The presence of S. aureus is a potential risk for wound infections,
especially if they produce virulence factors that outweigh the hosts’
ability to resist them. In fact, S. aureus is notorious for producing a
range of virulence factors that are involved in the persistence of
colonization, infection, tissue damage and delayed wound healing
(Bessa et al., 2015).
The major known virulence factors of S. aureus include cytolytic
toxins such as the hemolysins, α-toxin, various leucocidins (e.g. Panton-
Valentine Leucocidin [PVL] and exofoliative toxins [ETA and ETB]),
and phenol-soluble modulins [PSMs]), as well as superantigens such as
the toxic shock syndrome toxin-1 (TSST-1) (Prévost et al., 2001; Wang
et al., 2007). Production of particular virulence factors by S. aureus can
sometimes be related to speciﬁc diseases. This is exempliﬁed by the
toxic shock syndrome caused by TSST-1-positive isolates, or the
staphylococcal scalded skin syndrome caused by ETA- or ETB-positive
isolates (Todd et al., 1978). However, in general the severity of S.
aureus infection seems to be related to the range and amounts of
diﬀerent toxins that are simultaneously produced (Otto, 2012). In
addition, other virulence factors enhance the capacity of S. aureus to
survive in the human host. These include immune evasion factors, such
as staphylokinase (Sak), the staphylococcal inhibitor of complement
(SCIN), and the chemotaxis inhibitory protein (CHIPS). Most often
these virulence factors are encoded on mobile genetic elements (MGEs),
such as prophages, plasmids, genomic islands, staphylococcal cassette
chromosome (SCC) elements, and S. aureus pathogenicity islands
(SaPIs) (Novick, 2003). Additionally, the genome of S. aureus contains
speciﬁc genes with a function in pathogenesis and host adaptation.
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Many of these are controlled by the accessory gene regulator (agr)
system that has a major impact on the virulence of S. aureus (Novick
et al., 1993).
PVL is one of the prophage-encoded virulence factors implicated in
S. aureus necrotic skin lesions (Novick, 2003; Novick et al., 1993). The
PVL genes have been detected in 53–62% of S. aureus isolates from skin
and soft tissue infections (Kilic et al., 2015; Nurjadi et al., 2015; Pardos
de la Gandara et al., 2015). In a recent study, we observed that 79% of
the S. aureus isolates from wounds of BU patients treated with
streptomycin and rifampicin were PVL-positive (Amissah et al.,
2015b). Since M. ulcerans is eﬀectively killed upon this antibiotic
therapy, we hypothesized that the wound-resident S. aureus may still
aﬀect the soft tissue, thereby causing a delay in wound healing. As PVL
is one of many known S. aureus virulence factors, the present study
aimed to reveal all virulence genes present in S. aureus isolates from BU
patients. To this end, the genomes of 21 S. aureus isolates from the
anterior nares and wounds of BU patients were sequenced and analyzed
for the presence of known virulence genes.
2. Materials and methods
2.1. Ethical statement
The study was approved by the ethics committee of the Noguchi
Memorial Institute for Medical Research (FEDERAL WIDE ASSURANCE
FWA 00001824), and was carried out in accordance with the approval
guidelines. All samples were collected upon written informed consent from
adult subjects, or a parent or guardian of any child participant on behalf of
the respective child below 18 years. Speciﬁcally, samples were collected
from the anterior nares and wounds of eleven BU patients who received
treatment at the Pakro Health Center in the Eastern region of Ghana.
2.2. Bacterial isolates
The 21 S. aureus isolates used in this study are listed in Table 1.
Their isolation and initial characterization was described (Amissah
et al., 2015a). Speciﬁcally, four isolates were obtained from the anterior
nares and 17 from the wounds of eleven BU patients. These included six
methicillin resistant S. aureus (MRSA) and 15 methicillin susceptible S.
aureus (MSSA) isolates (Table 1).
2.3. Hemolytic activity of S. aureus isolates from BU patients
S. aureus isolates were grown overnight in 3 ml of Tryptic Soy Broth
(TSB) at 37 °C. A 10 μl loopful of the S. aureus RN4220 control strain
was streaked vertically at the center of freshly prepared 5% sheep blood
agar (BA) plates. Next, the 21 investigated S. aureus isolates from BU
patients were streaked perpendicularly on both sides of the RN4220
streak. Plates were incubated overnight at 37 °C after which the
possible synergistic hemolytic activity was assessed by visual inspection
of clearance zones due to the lysis of red blood cells.
2.4. Whole genome sequencing, sequence assembly and data analyses
Genomic DNA for whole genome sequencing (WGS) was obtained
from S. aureus isolates as previously described (Amissah et al., 2015a).
DNA libraries were prepared using the Nextera XT v2 kit (Illumina, San
Diego, CA, USA) according to the manufacturers’ instructions and then
run on a Miseq (Illumina), which resulted in paired-end reads of∼250-
bp. De novo sequence assembly was performed using the CLC Genomics
Workbench v7.0.4 package (CLC bio A/S, Aarhus, Denmark) after
quality trimming (Qs > 28) with optimal word sizes based on the
maximum N50 value. The sequence reads were submitted to the
National Center for Biotechnology Information GenBank and are
available under the BioProject PRJNA283747, SRP (raw reads) study
accession: SRP061319 and accession numbers: LGAE00000000,
LFTW00000000, LFTV00000000, LFTU00000000, LFTT00000000,
LFOH00000000, LFOG00000000, LFNS00000000, LFNR00000000,
LFNQ00000000, LFNP00000000, LFNO00000000, LFNN00000000,
LFNM00000000, LFNL00000000, LFNK00000000, LFNJ00000000,
LFNI00000000, LFNH00000000, LFMH00000000, LFMG00000000.
2.5. Screening for virulence genes and mobile genetic elements
De novo assembled genomes of sequenced S. aureus isolates were
queried against speciﬁc features of previously sequenced isolates, or
compared to the complete S. aureus reference genome of MRSA252 with
associated annotated genes (NCBI number: BX571856.1) using blastN
Table 1
Detection of genes for hemolysins and phenol soluble modulins.
Patient no. ST Straina Source of sample agr type hlab,c hlbb,d hldb Psm-αb Psm-βb
2 88 BU_G0201_t8* Wound III + a + + +
7 88 BU_G0701_t5* Wound III + a + + +
2 88 BU_G0202_t2* Wound III + a + + +
19 88 BU_G1905_t3* Wound III + a + + +
13 88 BU_W13_t1* Wound III + a + + +
22 5 BU_W22_t4 Wound II + a + + +
7 5 BU_W7A_t11* Wound II + a + + +
17 15 BU_N17Y_t2 Nose II + b + + +
3 15 BU_N3_t2 Nose II + b + + +
6 1 BU_W6_t1 Wound III m a + + +
12 121 BU_G1201_t13 Wound IV + a + + +
12 121 BU_G1201_t8 Wound IV + a + + +
26 121 BU_G2601A_t9 Wound IV + a + + +
22 3019 BU_N22_t6 Nose IV + a + + +
12 508 BU_W12_t13 Wound IV + a + + +
3 152 BU_G0301_t8 Wound IV + + + + +
10 152 BU_G1074_t4 Wound IV + + + + +
11 152 BU_G1101_t2 Wound IV + + + + +
10 152 BU_G1001_t8 Wound IV + + + + +
17 152 BU_N17W_t2 Nose IV + + + + +
7 152 BU_G0706B_t8 Wound IV + + + + +
a MRSA isolates are indicated by an asterisk.
b Detection of hemolysins and phenol soluble modulin genes is indicated by +.
c A frame shift mutation in the hla gene is marked by m.
d Insertion of a prophage and IEC genes in the hlb gene are marked a and b.
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in the WebACT comparison tool (http://www.webact.org/WebACT/
prebuilt#). Subsequent detailed analyses were performed with the
Artemis Comparison Tool (ACT) software (Carver et al., 2005).
Similarity matches were ﬁltered based on their length (100 kb seg-
ments) and percentage similarity scores, and only the ﬁltered hits with
at least 80% sequence similarity were then displayed by ACT (e-value of
10.00000) and analyzed in detail. Sequence data were queried for the
presence of staphylococcal enterotoxin genes (sea, seb, sec1, sec3, sec4,
sed, see, seg, seh, sei, sej, sek, sel, sem, sen, seo, sep and seq), the toxic
shock syndrome toxin-1 gene (tsst-1), exfoliative toxin genes (eta and
etb), cytolytic toxin genes, phenol-soluble modulin genes (psm-α, psm-β
and psm-γ) and PVL genes (lukF-PV and lukS-PV). In addition, the
presence of genes encoding proteins that have impact on the innate and
adaptive immune system was assessed, including genes for the chemo-
taxis inhibitory protein (chp), staphylokinase (sak) and staphylococcal
complement inhibitor (scn). Lastly, the presence of known and potential
prophages, genomic islands, SaPIs and SCCmec elements was investi-
gated by similarity searches.
3. Results
3.1. Dynamics of S. aureus in wounds of BU patients and wound healing
time
As reported previously we determined S. aureus diversity over time
in the wounds of 19 BU patients (Amissah et al., 2015b). Most of the
patients were diagnosed with category II wounds (i.e. lesions between 5
and 15 cm) and time to healing ranged from 2.75 to more than 6
months (Table 2). In most cases, the patients’ wounds were colonized
by MSSA, but MRSA was detected in the wounds of ﬁve patients. The
investigated wounds were colonized by S. aureus before, during, and
after antibiotic treatment (Amissah et al., 2015b). We observed that
three patients (patients 2, 10 and 11) were colonized with a single S.
aureus genotype over time, while two other patients (patients 13 and
19) were found to be positive with S. aureus only once during the study
period (Amissah et al., 2015b). Two diﬀerent S. aureus genotypes were
identiﬁed simultaneously at the same time point in the wounds of three
patients (patients 6, 12 and 26). Remarkably, the wounds of three
patients (patients 3, 22 and 7) were colonized over time with three, four
or even six diﬀerent S. aureus genotypes, respectively.
3.2. Detection of hemolysin and phenol soluble modulin genes
To assess the virulence genes of S. aureus isolates from the wounds
of BU patients, we ﬁrst queried the core genome for generally well-
conserved virulence genes, including those that encode α, β, and δ-
hemolysins (hla, hlb and hld) and phenol soluble modulins (psm-α and
psm-β). All investigated isolates harbored the hla gene. However, in one
isolate with sequence type 1 (ST1), it contained a frame shift mutation
caused by a nucleotide deletion (Table 1). The hlb gene was found to be
intact in all isolates that belonged to ST152, while in most other isolates
this gene was split into two parts by insertion of a prophage (φSa3).
However, in isolates belonging to ST15, the hlb gene was split by an
immune evasion gene cluster (IEC). The hld and the psm-α and psm-β
genes were present in all isolates (Table 1).
Despite the presence of hla encoding α-hemolysin in the genomes of
almost all sequenced isolates, α-hemolysin activity was observed only
in isolates that belonged to ST152 (Table 2). This may relate to the
limited sensitivity of the applied assay for weak α-hemolysin activity. β-
hemolysin activity was detected in ten isolates of which four belonged
to ST88 and six to ST152 (Table 2). The detection of a β-hemolysin-like
activity in the four ST88 isolates was unexpected as they lack an intact
hlb gene due to phage integration (Table 1). Lastly, 13 isolates
displayed δ-hemolysin activity (Table 2). Of note, two isolates belong-
ing to ST121 and ST508, respectively, did not display any hemolytic
activity, despite the presence of the hla and hld genes (Tables 1 and 2).
3.3. Virulence genes located on mobile genetic elements
To gain further insight into the genomic diversity of S. aureus
isolates from BU patients and the features that may inﬂuence host
colonization and infection, the genomes of the 21 sequenced isolates
were analyzed for the presence of mobile genetic elements that could
potentially encode virulence factors (Table 3). Indeed, 20 isolates
carried at least one prophage, while in one isolate belonging to ST15
no intact prophage was detected. Diﬀerent combinations of virulence
Table 2
Investigated S. aureus isolates and their hemolytic activity.




Time of culture isolation after start of treatment
(weeks)
Time to wound healing
(months)c
Hlad Hlbd Hldd
2 88 BU_G0201_t8 Wound II 16 > 6* + +
7 88 BU_G0701_t5 Wound II 7 6 + +
2 88 BU_G0202_t2 Wound II 4 > 6* + +
19 88 BU_G1905_t3 Wound II 2 > 6 + +
13 88 BU_W13_t1 Wound II 0 4.5 +
22 5 BU_W22_t4 Wound III 7 > 6* +
7 5 BU_W7A_t11 Wound II 20 6 +
17 15 BU_N17Y_t2 Nose N/A N/A N/A +
3 15 BU_N3_t2 Nose N/A N/A N/A +
6 1 BU_W6_t1 Wound III 0 4.5 +
12 121 BU_G1201_t13 Wound II 26 > 6* +
12 121 BU_G1201_t8 Wound II 14 > 6* +
26 121 BU_G2601A_t9 Wound II 3 3.5
22 3019 BU_N22_t6 Nose N/A N/A N/A +
12 508 BU_W12_t13 Wound II 26 6
3 152 BU_G0301_t8 Wound III 15 > 6* + +
10 152 BU_G1074_t4 Wound III 7 4.5 + +
11 152 BU_G1101_t2 Wound II 3 2.75 + +
10 152 BU_G1001_t8 Wound III 15 4.5 + +
17 152 BU_N17W_t2 Nose N/A N/A N/A + +
7 152 BU_G0706B_t8 Wound II 13 6 + +
a Abbreviations used: ST, sequence type; N/A, not applicable.
b Numbers indicate the category of lesions: I, lesions ≤ 5 cm; II, lesions between 5 and 15 cm; III, lesions ≥ 15 cm or lesions at critical sites such as the eye and genitals.
c An * indicates the end of observation.
d Hemolytic activity is indicated by a +.
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genes were encoded by the identiﬁed prophages. The most common
prophage type (φSa3) was identiﬁed in 19 S. aureus isolates. The
prophage φSa2 was detected in 17 isolates, but isolates belonging to
ST88 and ST3019 contained prophage φSa2 without the genes encod-
ing PVL. One ST15 isolate harbored the φSa6 that encoded the eta gene
(Table 3).
Interestingly, analysis of the integration sites of φSa3 showed three
genomic positions that may be occupied by this phage type (Fig. 1).
Most often this phage was found to split the hlb gene into two parts as
illustrated in Fig. 1 for ST88, ST5, ST1, ST121 and ST508 isolates (top
to bottom). This is similar to the situation encountered for phiNM3 in
strain Newman (DQ530361.1; Fig. 1) (Bae et al., 2006). Isolates
belonging to ST15 carried the IEC gene cluster (chp and scn) at the
hlb position, while an intact prophage was missing (not shown). The
second locus where the φSa3 prophage had inserted was into the hsdS
gene, which encodes a speciﬁcity subunit of the type I restriction
modiﬁcation system that is present within the β-genomic island (νSaβ).
This location of φSa3 was identiﬁed in the genomes of ﬁve ST152
isolates (Fig. 1 and Table 3). The third genomic position occupied by
φSa3 was a non-coding region which, in the reference genome
MRSA252, is located between the open reading frames (ORFs)
SAR0654 and SAR0655 (Fig. 2A). This location of φSa3 was only found
in the genome of one isolate belonging to ST152 (Fig. 1 and Table 3).
Except two ST508 and ST3019 isolates, the genomes of all other
isolates carried the lukD and lukE genes for a pore-forming toxin in the
highly variable νSaβ genome region (Table 3).
3.4. Novel pathogenicity islands
Analysis of the sequence data of the 21 isolates revealed the
presence of eight diﬀerent SaPIs. Remarkably, only one had been
previously identiﬁed whereas the other seven contained novel regions.
Furthermore, most of the identiﬁed SaPIs had mosaic structures
containing regions of known SaPIs as well as completely novel genes
not identiﬁed previously. We named these new pathogenicity islands
SaPIGhana1 to SaPIGhana7 (Table 3). SaPIGhana1 from isolate
BU_W22_t4 (ST5) is composed of regions belonging to SaPI2 and
harbors the ear gene that encodes for a penicillin-binding protein
(Fig. 3). Additionally, it contains two novel genes whose functions are
yet unknown. SaPIGhana2 from isolate BU_W7A_t11 (ST5) represents a
novel SaPI type that is similar to the SaPI from S. aureus strain OC3
(ST8) (Accession No. AB983199.1), which was previously isolated in
Japan. This SaPI carries the fhuD gene, encoding a ferrichrome-binding
protein that is important for growth under iron-restricted conditions.
Isolate BU_N17Y_t2 (ST15) contains SaPIGhana3, which is a SaPI1-like
element with a novel region with three genes of unknown function
downstream of the terminase gene. The isolate BU_W6_t1 (ST1)
contains two SaPIs. First, we found SaPIGhana4 that shares homologous
regions with SaPI1 and contains a novel region that includes the tst and
ear genes plus a truncated seb gene. The second pathogenicity island
found in this isolate, SaPIGhana5, shares homologous regions with
SaPImw2. However, this SaPI contains a novel region downstream of
the terminase gene with three novel genes and the eta gene. Three of
the isolates belonging to ST121 also contained two novel SaPIs.
SaPIGhana6 (Table 3) is composed of regions similar to two diﬀerent
Fig. 1. Diversity of φSa3 phages and their genomic integration sites in sequenced S. aureus isolates from BU patients. BLASTN-based alignment (nucleotide identity> 80% shown) of the
sequences of φSa3 bacteriophages identiﬁed in 21 sequenced Ghanaian S. aureus isolates as displayed by the Artemis comparison tool (ACT). The previously published DNA sequence of
phage phiNM3 from strain Newman (NCBI number: DQ530361.1) was used as a reference to compare with other bacteriophage sequences included in this alignment. Further,
representative φSa3 bacteriophages from S. aureus isolates of particular sequence types are shown (ST88 – BU_G0701_t5; ST5 – BU_W7A_t11; ST1 – BU_W6_t1; ST121 – BU_G2601A_t9;
ST508 – BU_W12_t13; ST152 – BU_G0301_t8 and BU_G0706B_t8). Red lines between compared sequences highlight orthologous sequences with the same orientation. Identiﬁed open
reading frames (ORFs) are colored in light blue, the integrase gene is marked in yellow, immune invasion cluster genes are indicated in pink and assigned with speciﬁc numbers (1- sae; 2
– sak; 3 – chp; 4 – scn). Phage integration points are indicated by roman numbers (I – hlb (green); II – hsdS; III – non-coding region).
N.A. Amissah et al. International Journal of Medical Microbiology 307 (2017) 223–232
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pathogenicity islands namely SaPImw2 and SaPIj11, and it harbors the
two enterotoxin genes sek and seq. The second SaPI, SaPIGhana7,
harbors both novel regions and contains regions with high similarity to
the previously identiﬁed SaPIIVm10 (SaPI4). Further, SaPIGhana7
carries the seb and ear genes. Lastly, the SaPI identiﬁed in isolate
BU_W12_t13 (ST508) shares overall similarity with the previously
identiﬁed SaPI68111. This SaPI carries the tst, ear, seb and sel genes.
Amongst the analyzed isolates, SaPIs were identiﬁed at four diﬀerent
genomic positions as mapped on the reference genome of the MRSA252
strain (Fig. 2B). SaPIGhana4 and 7 had integrated upstream the gene
coding for the hypothetical protein SAR0365. A second SaPI integration
point, where SaPIGhana2, 5 and SaPI68111 were identiﬁed, was
located downstream of the smpB gene coding for the putative tmRNA-
binding protein SAR0837. A third integration point, where SaPIGhana 3
and 6 were found, was located downstream of the ORF coding for the
methionine ABC transporter SAR0871. The fourth integration site
Fig. 2. Genomic positions of integrated φSa3 phages (A) and SaPIs (B). The identiﬁed φSa3 phages and SaPIs in sequenced S. aureus isolates are projected onto the MRSA252 reference
genome. The integration sites are indicated with blue squares. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
N.A. Amissah et al. International Journal of Medical Microbiology 307 (2017) 223–232
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containing SaPIGhana1 was located downstream of the groEL gene.
3.5. Genomic regions downstream the SCCmec insertion site in S. aureus
isolates from BU patients
The integration site of known SCCmec elements is localized at the
rlmH gene (previously designated orfX), encoding a methyltransferase.
A detailed inspection of the region downstream of rlmH in the
sequenced MRSA and MSSA isolates showed that it was conserved in
isolates of the same sequence type. However, it diﬀered substantially
with respect to gene content in isolates of diﬀerent sequence types.
Novel genomic regions downstream of rlmH integration sites were
found in sequenced isolates belonging to ST88, ST152 and ST3019. Five
of the investigated ST88 isolates were MRSA that carried SCCmec IVa.
Interestingly, all these ﬁve isolates contained a novel DNA fragment of
7 kb downstream of the SCCmec element that includes eight open
reading frames of unknown function (Fig. 4). In this fragment, a stretch
of 3.6 kb shares 89% sequence similarity with a corresponding region of
the SCC element present in S. haemolyticus strain SH480 (GenBank:
AB477967.1).
Of note, a novel region of 5 kb in size was identiﬁed downstream of
rlmH in ST152 MSSA isolates. This region contains six novel genes
encoding hypothetical proteins (Fig. 4). The one investigated ST3019
MSSA isolate carried an SCC element with a cap operon that encodes for
capsular polysaccharide in S. aureus. Downstream of this novel SCC, a
new genomic region of 10 kb in size was identiﬁed that contained 9
novel open reading frames not reported before. Further, ﬁve diﬀerent
but previously characterized genomic regions downstream of rlmH were
encountered in the remaining MSSA isolates. Speciﬁcally, in the ST5
MSSA isolates the analyzed genomic region downstream of rlmH was
identical to that of the S. aureus isolates ED98 (GenBank: CP001781.1)
and 502A (GenBank: CP007454.1). In ST15 isolates the region down-
stream of rlmH was identical to the respective region of the previously
reported 15666 SCCmec insertion site (Noto et al., 2008). The ST1
MSSA isolate had a genomic region downstream of rlmH identical to the
region described previously as the 15575 SCCmec insertion site genomic
sequence, which contains the gene for the enterotoxin Seh. The MSSA
isolates with ST121 contained genomic regions downstream of rlmH
that were identical to the respective region described as the 3289
SCCmec insertion site genomic sequence, which carries the sec2
enterotoxin gene. The genomic region downstream rlmH in the ST508
isolate is identical to the corresponding region of MRSA strain CA-347
(GenBank: CP006044.1) (Fig. 4). This region was found to encode a
restriction-modiﬁcation system (hsdR hsdM) and to include a MGE
encoding an ErmB/QacA drug resistance transporter of the major
facilitator superfamily (MFS).
Lastly, all investigated isolates contained genomic islands νSaα and
νSaβ with varying sets of genes encoding exotoxins, enterotoxins,
lipoproteins and serine proteases that target elements of the innate
immune response (Table 3). In addition, the ST1 isolate was found to
encode a third pore-forming leukocyte toxin, encoded by the lukM and
lukS genes.
Fig. 3. Diversity of SaPIs and their integration sites in sequenced S. aureus isolates from BU patients. Open reading frames (ORFs) are indicated by arrows. Homologous regions to known
SaPIs are indicated by colored blocks. Hypothetical ORFs are indicated in blue; the SaPI integrase gene (int) is marked in green; genes encoding virulence factors are indicated in orange;
novel ORFs are indicated by yellow arrows. ter represents the SaPI terminase gene.
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4. Discussion
The pathogenesis of BU is associated with mycolactone, the main
virulence factor of M. ulcerans that is responsible for tissue necrosis and
suppression of the immune response of BU patients (George et al., 2000,
1999). The resulting wounds are subsequently colonized with diﬀerent
bacteria, including S. aureus (Amissah et al., 2015b; Barogui et al., 2013).
We hypothesize that S. aureus is one of the drivers of delayed wound
healing, besides other factors such as poor nutrition and inadequate
wound management. In the ideal situation, wound management in BU
should include rinsing with saline, and the application of vaseline gauze
topped with absorptive dressing material and compression, preferably
with a short-stretched bandage. Poor wound management and transmis-
sion events during wound care predispose the wounds of BU patients to
colonization with microorganisms including S. aureus (Amissah et al.,
2015a; Velding et al., 2014). Hence small lesions (<10 cm) that are
expected to heal within two to four weeks of antibiotic therapy take longer
time to heal. For example, in one large trial with drug treatment alone, it
took patients a median 18 weeks to heal (Nienhuis et al., 2010). This may
at least partially be due to the colonization with bacteria including S.
aureus. In our present study, it took 6 months for most category II wounds
colonized with S. aureus to heal (Table 2) compared to 3–4 months for
patients not colonized with S. aureus (data not shown). Furthermore,
temporal changes in S. aureus genotypes were observed in the wounds of
some BU patients (Amissah et al., 2015b). Here, we observed diﬀerent S.
aureus genotypes containing additional virulence genes over time (patients
7 and 12) (Table 3). Thus BU wounds that are not healed after two months
of antibiotic therapy may even be re-colonised with new S. aureus
genotypes that can be more virulent than the original colonizing S. aureus.
In this respect, it is noteworthy that the S. aureus genotypes identiﬁed in
BU wounds have also been detected in the nares, skin and soft tissue
infections, and bacteraemia in Ghana and other African countries
(Conceicao et al., 2015; Egyir et al., 2014; Kraef et al., 2015; Ruimy
et al., 2008; Shittu et al., 2012). In fact, in Ghana, S. aureus contributes
largely to bacteraemia (10.8–13.2%) (Anyebuno and Newman, 1995;
Nielsen et al., 2012). Further, patients with skin infections such as BU are
heavily colonized with S. aureus (Amissah et al., 2015b; Barogui et al.,
2013). The BU lesions are often colonized by S. aureus during disease
management, i.e. during and after antimicrobial therapy and wound
management (Amissah et al., 2015b). In this respect, it should be noted
that none of the patients in this study were prescribed antibiotics other
than the topical antibiotics used during wound dressing.
The present study characterized the virulence genes in S. aureus
isolated from BU patients. Genes for staphylococcal virulence factors
are often encoded by MGEs, such as prophages, plasmids, genomic
islands and SaPIs. Accordingly, the present study attributed particular
Fig. 4. Structure of genomic regions downstream of SCCmec insertion sites in sequenced S. aureus isolates from BU patients. Open reading frames (ORFs) are marked by arrows and
truncated ORFs are indicated by * above the arrow; rlmH (orfX) is indicated in yellow; hypothetical ORFs are indicated in blue; genes coding for antibiotic resistance are indicated in red;
genes encoding virulence factors are indicated in black; and direct repeats are marked by a black arrow head. The novel genomic regions present in isolates of ST88, ST152 and ST3019
are indicated with grey shading.
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attention to MGEs and the encoded virulence and resistance genes. In
many isolates α-, β- and δ-hemolysin genes were found, whereas their
activity was only detected in some investigated S. aureus isolates. In the
case of two agr-positive MSSA isolates (ST121 and ST508; agr type IV;
Table 1) no hemolytic activity was detectable. For the respective ST508
isolate, this phenotype may be explained by multiple mutations in the
agrC locus and RNAIII. On the other hand, in the non-hemolytic ST121
isolate, the only mutation detected in the agr locus concerned the
insertion of one adenine in the RNAIII region. It is presently not clear
whether this explains the non-hemolytic phenotype. Alternatively, it is
conceivable that the lack of hemolytic activity was due to a suppression
of agr function by upstream regulators, such as sigB, as was previously
reported for glycopeptide-intermediate resistant S. aureus (Bischoﬀ
et al., 2001; Bischoﬀ and Berger-Bachi, 2001; Renzoni et al., 2004;
Sakoulas et al., 2006). The latter observation has been associated with
the ability of MRSA to survive under glycopeptide selective pressure.
Further studies are needed to understand the mechanism of the loss of
hemolytic activity in the MSSA isolates under rifampicin selection
pressure against which one isolate is resistant. Of note, the method used
in the detection of hemolytic activity may not be sensitive enough for
the detection of weak α-hemolysin activity, which is a potential
limitation in this study. Conceivably, the pore-forming activity of the
detected hemolysins may contribute to tissue necrosis in wounds of BU
patients after antibiotic therapy of the primary infection caused by M.
ulcerans. On the other hand, the virulence of some isolates in our study
may be aﬀected to some extent by the integration of a prophage or the
IEC gene cluster in the hlb gene. Indeed such genetic changes have been
reported to have the potential to enhance the pathogenicity of the
isolates (Salgado-Pabón et al., 2014). Intriguingly, four isolates belong-
ing to ST88 showed high a β-hemolysin-like activity despite the
insertion of a prophage in hlb. This implies that an as yet unidentiﬁed
other factor with β-hemolysin-like activity is responsible for this
phenotype.
MGEs such as (pro)phages represent a driving force in staphylococ-
cal host adaptation and infection (Wagner and Waldor, 2002). Con-
sistent with this view, almost all isolates carried phage-encoded
virulence factors, particularly those involved in phagocyte evasion by
inhibiting phagocytosis (CHIPS, SCIN, Sak, and Sea) and by directly
attacking phagocytes (PVL) (van der Vijver et al., 1972). The insertion
of the φSa3 prophage, which encodes CHIPS, SCIN, Sak and Sea, into
the hlb gene has been reported to serve as a regulator of virulence gene
expression by increasing ﬁtness and virulence in new infection niches
(Salgado-Pabón et al., 2014). It seems likely that this will also be true
for most of the presently investigated isolates.
Seven novel SaPIs were identiﬁed in the sequenced S. aureus isolates
from BU patients. These were shown to carry genes for virulence
factors, such as ear, seb, sae, sek, sel, seq, tst-1 and eta, suggesting that
the respective staphylococci have the ability to cause infections like
sepsis, toxic shock syndrome and scalded skin syndrome (Fraser et al.,
2000; Holtfreter and Bröker, 2005; Yamasaki et al., 2005). More
importantly, certain combinations of staphylococcal toxin genes re-
ported to be rare and associated with mortality were found in the
investigated isolates (Ambrozova et al., 2013). For instance, SaPIGha-
na4 encoding tst-1, seb, sae, φSa2 encoding lukF and lukS, φSa3
encoding sea, sak, chp, scn, sel, sek, and the additional virulence factors
lukM/lukS, seh, sej, ser, seh were detected in the genomes of S. aureus
isolated from wounds. Further, the enterotoxin-encoding genes seg, sei,
sem, sen, seo located in the enterotoxin gene cluster (egc) were often
identiﬁed in isolates harboring the novel SaPIs. Epidemiological data
suggests that egc facilitates the colonization of mucosal surfaces, which
precedes local and invasive infection and is associated with lower
disease-invoking potential as compared to S. aureus superantigens
(Ferry et al., 2005). This may be one reason why serious infections,
such as sepsis or toxic shock syndrome, did not occur in the BU patients
from whom the investigated S. aureus isolates were obtained. Indeed,
none of the patients were clinically suspected of having a secondary
infection with or were treated for a suspected S. aureus infection. This
suggests that the presence of certain virulence genes may counteract the
eﬀects of other virulence factors. It also suggests that multiple virulence
factors encoded on MGEs may contribute diﬀerentially to the survival
and persistence of S. aureus in the wound. However, the conﬁrmation of
this idea awaits experimental veriﬁcation through expression analyses
and testing the isolates in appropriate animal infection models.
The known SCCmec integration site located at rlmH (orfX) deserves
special attention also in MSSA isolates, because this genomic region
seems to be attractive for integration of other non-SCCmec elements
that may encode virulence or ﬁtness-enhancing determinants. This was
clearly the case in isolates belonging to ST1, ST121 and ST508 that
were found to harbor at this locus the enterotoxins genes seh or sec2, or
the gene encoding an EmrB/QacA drug resistance transporter, respec-
tively (Amissah et al., 2015b). The identiﬁcation of an SCC element
with a cap operon in an S. aureus ST3019 isolate suggests that this
isolate may have acquired a ﬁtness advantage as well as a phagocytosis-
resistance phenotype (Luong and Lee, 2002; Pardo et al., 2009; Voyich
et al., 2005). However this needs to be further investigated.
The virulence genes sea, sei, lukDE, lukF-PV, lukS-PV, hlgv and cap8 have
been associated with moderate to severe infections in diabetic foot ulcers
(grades 2–4) (Messad et al., 2013; Sotto et al., 2008). For S. aureus isolates
that cause invasive infections, the cap5, lukDE and scn genes, as well as
genes encoding ﬁbronectin-binding protein (fnbB), serine proteases A and B
(splA/splB), and staphylococcal exotoxin-like proteins (setC or seIX) have
been reported to be frequently present (Rasmussen et al., 2013). Although
some virulence genes are reported to be associated with severe infections in
diabetic ulcers and in patients with invasive staphylococcal disease, this
study lacks the metadata to make such inference. Nonetheless, one
observation is noteworthy in this respect, namely that the nasal isolates
from patients 3 and 22 seem to have fewer SaPIs, prophages and virulence
genes than the wound isolates from these patients (Table 3). However, it
should be noted that the respective nasal and wound isolates belonged to
diﬀerent sequence types, which makes it diﬃcult to speculate about possible
diﬀerences in the virulence of these isolates.
In conclusion, the sequence data of S. aureus isolates from BU patients
uncovered a large but variable reservoir of MGEs and virulence genes that
may enhance their survival and persistence in the human host. In particular,
we identiﬁed seven novel enterotoxin-encoding SaPIs from BU patients. It
should however, be noticed that this study provides only a ﬁrst inventory of
the virulence potential of the investigated isolates. Accordingly, we cannot
yet correlate clinical data (e.g. percentage change in wound size over time)
with the presence or absence of particular virulence genes. In addition, the
virulence potential or presence of other bacteria such as Pseudomonas
aeruginosa, Escherichia coli, Acinetobacter baumannii, Klebsiella pneumonia and
S. haemolyticus, isolated from BU wounds could contribute to the delay in
wound healing of patients as well (Amissah et al., 2015b). Consequently,
without further studies on the expression of virulence factors of wound-
resident S. aureus and other microorganisms, the role of S. aureus in
potentially causing delay in wound healing is presumptive and needs to be
proven in further research.
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